+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Killer antibodies in fungal infections

Killer antibodies in fungal infections

Igiene Moderna 112(Suppl. 1): 329-336

An experimental model of idiotypic vaccination and antiidiotypic therapy mediated by antibodies representing the internal image of a yeast killer toxin characterized by the broad spectrum of antimicrobial activity is discussed. The experimental model is based upon the physiological antibody immune response elicited during natural infections caused by microorganisms expressing specific yeast killer toxin cell wall receptors.

(PDF emailed within 0-6 h: $19.90)

Accession: 003486733

Download citation: RISBibTeXText

DOI: 10.1016/s0923-2494(98)80757-8

Related references

Killer antibodies in fungal infections. Research in Immunology 149(4-5): 334-43; Discussion 523, 1998

Killer anti-idiotypes in the control of fungal infections. Current Opinion in Investigational Drugs 2(4): 477-479, 2001

Safety and efficacy of activated transfected killer cells for neutropenic fungal infections. Journal of Infectious Diseases 201(11): 1708-1717, 2010

Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies. Antimicrobial Agents and ChemoTherapy 50(9): 3090-3097, 2006

From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy. Antonie van Leeuwenhoek 99(1): 35-41, 2011

The role of antibodies against hsp90 in the treatment of fungal infections. Drug News & Perspectives 16(4): 205-210, 2003

Correction of aging phenotype in the liver. Aging, 2018

Apoc Social: A Mobile Interactive and Social Learning Platform for Collaborative Solving of Advanced Problems in Organic Chemistry. Chimia 72(1): 43-47, 2018

Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation. Annual Review of Microbiology 42: 517-545, 1988

Dermatophytoses, some subcutaneous fungal infections: chromoblastomycosis, mycetoma, entomophthoromycosis and dimorphic fungal skin infections. Fungi in human and animal health: 1-28, 2004

Monoclonal antibodies incorporated into Neotyphodium coenophialum fungal cultures: inhibition of fungal growth and stability of antibodies. Fungal Genetics and Biology 33(2): 107-114, 2001

Some observations on fungal infections in tropical climates. Fungal infections in Hong Kong (1952). Proc. roy. Soc. Med, 55: 7, 559-561, 1962

Systemic fungal infections in Japan: analysis of a questionnaire regarding the incidence of fungal infections. Japanese Journal of Antibiotics 54(8): 448-469, 2001

Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans. Plant Biotechnology Journal 9(7): 776-787, 2011

Fungal viruses and killer factors ustilago maydis killer proteins. Molitoris, H P , M Hollings And H A Wood (Ed ) Proceedings in Life Sciences: Fungal Viruses; 12th International Congress Of Microbiology, Mycology Section, Munich, West Germany, Sept 3-8, 1978 Xiv+194p Springer-Verlag: Berlin, West Germany; New York, N Y , Usa Illus P120-128, 1979